Jason V. Coloma, Chief Executive Officer at Maze Therapeutics, Inc. (MAZE), sold 22,638 shares at $26.38 ($594K) on 2026-09-02, disclosed to the SEC on 2026-09-04.
Open-market sale of $594k MAZE by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.38 | 9,852 | $260K | 43.8% |
| 2 | $27.12 | 1,375 | $37K | 6.3% |
| 3 | $25.77 | 129 | $3K | 0.6% |
| 4 | $26.01 | 11,282 | $293K | 49.4% |
| Total | $26.24 avg | 22,638 | $594K | 100% |
| Filing → |
| MAZE | SELL | 2026-07-02 | $1.0M | — | Filing → |
| MAZE | SELL | 2026-06-24 | $725K | — | Filing → |
| MAZE | SELL | 2026-06-03 | $174K | — | Filing → |